PharmaSynergy-Korea is taking place on February 23-24 in Amsterdam (and online)
PharmaSynergy Korea is a partnering event for the BD & Licensing pharma & biopharma executives fostering their overseas activity and facilitating international business development. PharmaSynergy Korea is a powerful combination of pre-arranged one-2-one meetings and a stimulating programme that highlights partnership case studies, expansion/entry strategies, registration processes and go-to-market considerations, as well as best practice of how such agreements are reached, including the practical aspects that are instrumental to success.
Product portfolio focus:
- Biosimilars & biobetters
- Specialty, injectables, general medicine
- South Korea + worldwide
- Exploring the potential of Korean Specialty Medications and injectables
- International growth and cross-border deals in general medicine segments
- Overview of South Korean programmes that are focused on promoting the development of biosimilars and bio-betters
The objective of the event is to highlight and foster international discussions for BD & Licensing deals and to facilitate partnership meetings with overseas companies interested in establishing licensing agreements with Korean market players.